readthroughSign in
CompanyKYMRNasdaqWatertown, MA

Kymera Therapeutics, Inc.

Kymera Therapeutics develops targeted protein degradation therapies—oral small molecule degraders for immunological diseases.

10-QNov 13Latest SEC filing
Nov 3Latest story